Oncotarget

Priority Research Papers:

SHIP represses lung inflammation and inhibits mammary tumor metastasis in BALB/c mice

Melisa J. Hamilton _, Elizabeth C. Halvorsen, Nancy E. LePard, Momir Bosiljcic, Victor W. Ho, Vivian Lam, Judit Banáth, Kevin L. Bennewith and Gerald Krystal

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:3677-3691. https://doi.org/10.18632/oncotarget.6611

Metrics: PDF 1282 views  |   HTML 1703 views  |   ?  


Abstract

Melisa J. Hamilton1, Elizabeth C. Halvorsen1, Nancy E. LePard1, Momir Bosiljcic1, Victor W. Ho2, Vivian Lam2, Judit Banáth1, Kevin L. Bennewith1,*, Gerald Krystal2,*

1Department of Integrative Oncology, British Columbia Cancer Agency Research Centre, Vancouver, BC, Canada

2Terry Fox Laboratory, British Columbia Cancer Agency Research Centre, Vancouver, BC, Canada

*These authors have contributed equally to this work

Correspondence to:

Kevin L. Bennewith, e-mail: kbennewi@bccrc.ca

Keywords: SHIP, BALB/c, 4T1, metastasis, myeloid cells

Received: September 12, 2015     Accepted: November 26, 2015     Published: December 14, 2015

ABSTRACT

SH2-containing-inositol-5’-phosphatase (SHIP) is a negative regulator of the phosphatidylinositol-3-kinase pathway in hematopoietic cells and limits the development of leukemias and lymphomas. The potential role of SHIP in solid tumor development and metastasis remains unknown. While SHIP restricts the aberrant development of myeloid cells in C57BL/6 mice, there are conflicting reports regarding the effect of SHIP deletion in BALB/c mice with important consequences for determining the influence of SHIP in different model tumor systems. We generated SHIP-/- BALB/c mice and challenged them with syngeneic non-metastatic 67NR or metastatic 4T1 mammary tumors. We demonstrate that SHIP restricts the development, alternative-activation, and immunosuppressive function of myeloid cells in tumor-free and tumor-bearing BALB/c mice. Tumor-free SHIP-/- BALB/c mice exhibited pulmonary inflammation, myeloid hyperplasia, and M2-polarized macrophages and this phenotype was greatly exacerbated by 4T1, but not 67NR, tumors. 4T1-bearing SHIP-/- mice rapidly lost weight and died from necrohemorrhagic inflammatory pulmonary disease, characterized by massive infiltration of pulmonary macrophages and myeloid-derived suppressor cells that were more M2-polarized and immunosuppressive than wild-type cells. Importantly, while SHIP loss did not affect primary tumor growth, 4T1-bearing SHIP-/- mice had 7.5-fold more metastatic tumor cells in their lungs than wild-type mice, consistent with the influence of immunosuppressive myeloid cells on metastatic growth. Our findings identify the hematopoietic cell-restricted protein SHIP as an intriguing target to influence the development of solid tumor metastases, and support development of SHIP agonists to prevent the accumulation of immunosuppressive myeloid cells and tumor metastases in the lungs to improve treatment of metastatic breast cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 6611